Could lithium ease symptoms of rare Autism-Linked condition?
NCT ID NCT06776848
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether lithium carbonate can improve behavior and thinking in people with a rare genetic disorder caused by changes in the TBR1 gene. Twelve participants aged 6 and older will take lithium for 24 months after a 6-12 month observation period. The goal is to see if the treatment is safe and helps with daily living skills.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROVEN PATHOGENIC OR PROBABLY PATHOGENIC TBR1 VARIANT are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHU Dijon Bourgogne
RECRUITINGDijon, 21000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••